CLEC14A was initially classified as a tumour endothelial marker based on immunohistochemical staining of multiple distinct tumour types, with strong staining on tumour‐associated vessels in contrast to a near absence of staining in healthy tissues 189. This evidence concerns the gene CLEC14A and neoplasm.